Kathleen Kelley, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St, Ste 100, Granger, IN 46530 Phone: 574-647-3376 Fax: 574-647-2951 |
News Archive
VCU Massey Cancer Center researchers have identified a protein involved in milk production that stimulates the growth and spread of breast cancer and could ultimately serve as a target for novel therapies to treat breast cancer.
Porvair Sciences has published a new guide to help laboratories choose the best way to verify the quality and quantity of their Chromatin Immunoprecipitation (ChIP) DNA.
Nymox Pharmaceutical Corporation today announced new 2010 positive results from a long term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study evaluated symptomatic progress of U.S. patients involved in the Company's NX02-0012 and NX02-0013 Phase 1-2 studies of NX-1207 initially undertaken in 2003. Patients treated with NX-1207 were followed-up on an unselected and as available basis and assessed for symptomatic improvement, treatment outcomes, and durability of efficacy 6 ½ years after a single treatment with NX-1207.
Four out of 10 medical students feel they can justify having a sexual relationship with a patient, suggests a small study in the Journal of Medical Ethics. Furthermore, their views seem to change little as they move through their training, shows the study.
› Verified 9 days ago